Association Between Obesity and Menstrual Irregularities in Women of Reproductive Age.
DOI:
https://doi.org/10.63682/jns.v15i1s.10450Keywords:
Obesity, Menstrual Irregularities, BMI, Central Adiposity, Hormonal Imbalance, Reproductive HealthAbstract
Introduction: Obesity is an important global health problem impacting on reproductive health. Menstrual abnormalities including oligomenorrhea, amenorrhea and dysmenorrhea are related to higher body mass index (BMI) and central adiposity in female of reproductive age. While hormonal changes and metabolic and lifestyle abnormalities play a role in such disturbances, this interaction is yet not fully quantified.
Method: This systematic review was conducted in line with PRISMA 2020 guidelines, synthesizing data from 16 observational studies with cross-sectional, case-control and prospective cohort designs published between 2000 and 2026. Eligible studies assessed BMI or WC or WHR and menstrual outcomes, and/or hormone profiles. Data extracted included data on sample characteristics, anthropometric measures, cycle irregularities, and effect estimates (OR/aOR). The Newcastle-Ottawa Scale for cohort studies and JBI criteria for cross-sectional and case-control studies were used for quality assessment.
Results: BMI and central adiposity were always associated with menstrual irregularities risk. Longitudinal studies have shown that BMI reduction is associated with reduced odds of irregularities (aOR 0.34-0.39), with class III obesity having the greatest risk. Increased estradiol and decreased progesterone levels, decreased SHBG, and insulin resistance were among the hormonal mediators. The underweight women were also found to have irregularities, thus revealing a U-shaped relationship. These effects were modulated by regional/lifestyle differences, with South Asian women showing heightened susceptibility.
Conclusion: Metabolic and hormonal alterations provide a pathway by which obesity can affect menstrual function in a modifiable manner. Once the weight and lifestyle aspects have been targeted, the regularity in the cycle can be revamped. Future studies are required to standardise measurements, to broaden a hormonal profiling and to use digital monitoring for realistic implementation...
Downloads
References
World Health Organization. Obesity and Overweight. 2025 May 7. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
2. Fielder S, Nickkho-Amiry M, Seif MW. Obesity and menstrual disorders. Best Pract Res Clin Obstet Gynaecol. 2023;89:102343. https://doi.org/10.1016/j.bpobgyn.2023.102343
3. Lord M, Sahni M. Amenorrhea, Secondary. StatPearls. 2024 Oct 28. Available from: https://www.ncbi.nlm.nih.gov/books/NBK431055/
4. Martinez-Barbitta M, Biagini A, Costanzi E, et al. Adipose-Specific Cytokines as Modulators of Reproductive Activity. Biomedicines. 2025;13(12):3067. https://doi.org/10.3390/biomedicines13123067
5. CDC. Diabetes and Polycystic Ovary Syndrome (PCOS). 2024 May 21. Available from: https://www.cdc.gov/diabetes/risk-factors/pcos-polycystic-ovary-syndrome.html
6. Tanasescu MD, Rosu AM, Minca A, et al. Adipose Tissue Circadian Dysregulation Beyond BMI: Implications for Cardiometabolic Risk and Cardiovascular Disease. Life. 2026;16(2):305. https://doi.org/10.3390/life16020305
7. Cowan S, Lim S, Alycia C, et al. Lifestyle management in polycystic ovary syndrome – beyond diet and physical activity. BMC Endocr Disord. 2023;23(1). https://doi.org/10.1186/s12902-022-01208-y
8. NICE. Overweight and Obesity Management NICE Guideline. 2025. Available from: https://www.nice.org.uk/guidance/ng246/resources/overweight-and-obesity-management-pdf-66143959958725
9. American College of Obstetricians and Gynecologists. Polycystic Ovary Syndrome (PCOS). 2022 Jan. Available from: https://www.acog.org/womens-health/faqs/polycystic-ovary-syndrome-pcos
10. Shirvanizadeh F, Eidi A, Hafezi M, Eftekhari-Yazdi P. Abdominal Obesity May Play a Significant Role in the Exacerbation of Inflammation in Patients with Polycystic Ovary Syndrome. JBRA Assist Reprod. 2023;27(4):682–688. https://doi.org/10.5935/1518-0557.20230065
11. Namdev G, Naz S. Association of menstrual pattern with lifestyle factors among female medical students. Muller J Med Sci Res. 2021;12(2):75. https://doi.org/10.4103/mjmsr.mjmsr_33_21
12. Tang Y, Chen Y, Feng H, Zhu C, Tong M, Chen Q. Is body mass index associated with irregular menstruation: a questionnaire study? BMC Womens Health. 2020;20(1). https://doi.org/10.1186/s12905-020-01085-4
13. Srikanth J, Kumari N, Rajanna P. A cross-sectional study on obesity and menstrual abnormalities among women of reproductive age in urban field practice area of Kempegowda Institute of Medical Sciences, Bangalore. Int J Community Med Public Health. 2019;6(8):3252. https://doi.org/10.18203/2394-6040.ijcmph20193436
14. Hermawati R, Praja DW, Umam K. A Cross-Sectional Study of the Relationship Between BMI and Menstrual Cycle Regularity in Women of Reproductive Age in Pamekasan. Ascarya J Isl Sci Cult Soc Stud. 2025;5(1):129–141. https://doi.org/10.53754/4jtssc51
15. Bharti J, Singh A, Gupta B. Association of Body Mass Index with Menstrual Irregularities and Infertility among Women of Reproductive Age Group. Int J Curr Pharm Rev Res. 2026;18(01). https://doi.org/10.25258/ijcpr.18.1.232
16. Memon E, Aamir F, Waheed A, Gehani K, Fariha S, Naqvi S. Association of menstrual irregularity with obesity. Rawal Med J. 2022;47(3):589–593.
17. Mazcuri M, Riaz S, Khalid U, Kirshan S. Evaluation of obesity in females with abnormal menstrual cycle. Biol Clin Sci Res J. 2023;2023(1):352. https://doi.org/10.54112/bcsrj.v2023i1.352
18. Itoi S, Sampei M, Tatsumi T, Ishida R, Izumi G, Osuga Y, Koga K, Narumi S, Morisaki N. Within-individual changes in BMI and menstrual irregularity: a cohort study using real-world data. BMC Womens Health. 2026;26(1). https://doi.org/10.1186/s12905-026-04308-2
19. Itoi S, Sampei M, Tatsumi T, Osuga Y, Koga K, Narumi S, Morisaki N. Body mass index and menstrual irregularity in a prospective cohort study of smartphone application users. Npj Women S Health. 2025;3(1). https://doi.org/10.1038/s44294-025-00065-z
20. Souza C, Dias R, Fernandes CE, Pimentel F, Dias D. Menstrual irregularity: a possible clinical marker of metabolic dysfunction in women with class III obesity. Gynecol Endocrinol. 2010;26(10):768–772. https://doi.org/10.3109/09513590.2010.487603
21. Zhou X, Yang X. Association between obesity and oligomenorrhea or irregular menstruation in Chinese women of childbearing age: a cross-sectional study. Gynecol Endocrinol. 2020;36(12):1101–1105. https://doi.org/10.1080/09513590.2020.1803823
22. Wei S, Schmidt MD, Dwyer T, Norman RJ, Venn AJ. Obesity and Menstrual Irregularity: Associations With SHBG, Testosterone, and Insulin. Obesity. 2009;17(5):1070–1076. https://doi.org/10.1038/oby.2008.641
23. Ashraf S, Ziarat A, Shabbir A, et al. Association of BMI With Estrogen–Progesterone Imbalance and Menstrual Irregularity in Obese Women: Cross-Sectional Analytical Evidence From 80 Participants. J Health Wellness Community Res. 2025;e760. https://doi.org/10.61919/j1nxvd07
24. Yeung EH, Zhang C, Albert PS, et al. Adiposity and sex hormones across the menstrual cycle: the Biocycle Study. Int J Obes. 2012;37(2):237–243. https://doi.org/10.1038/ijo.2012.9
25. Ko KM, Han K, Chung YJ, Yoon KH, Park YG, Lee SH. Association between Body Weight Changes and Menstrual Irregularity: The Korea National Health and Nutrition Examination Survey 2010 to 2012. Endocrinol Metab. 2017;32(2):248. https://doi.org/10.3803/enm.2017.32.2.248
26. Sravanthi V, Keerthipriya A, Kezia D. Association Between BMI and Menstrual Irregularities in Women of Reproductive Age. Int J Curr Pharm Rev Res. 2026;18(02). https://doi.org/10.25258/ijcpr.18.2.179
27. Zhang E, Li X, Zhang B, Cai L, Tao X, Xing W, Tao X. Relationship Between Obesity and Menstrual Disturbances Among Women of Reproductive Age. Heart. 2012;98(Suppl 2):E156. https://doi.org/10.1136/heartjnl-2012-302920h.3
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.